A simulation modeling study examining the downstream effects of follow-up schedules for screen-detected nodules
- Determine whether the Lung-RADS guidelines are optimal for follow-up and treatment of lung nodules
- Investigate modifications to Lung-RADS with the aim of improving effectiveness
- Examine the cost-effectiveness of Lung-RADS and other such sets of guidelines
- Formulate recommendations for lung nodule management
Mark Hammer, M.D. (Brigham and Women's Hospital)
Eduardo Barbosa Jr., M.D. (U. Penn Perelman School of Medicine)